Here are the S-3 shelf registrations from Climb Bio, Inc. (CLYM) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
An S-3 covers the shelf registration that lets an established company sell over time, so if you follow CLYM and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CLYM filings page.
Climb Bio, Inc. is registering the resale of up to 11,587,000 shares of its common stock via a prospectus dated May 29, 2026, to permit selling stockholders to resell shares acquired in a recent private placement and related transactions. The registered shares consist of 9,481,000 outstanding shares held by the selling stockholders and 2,106,000 shares issuable upon exercise of prefunded warrants held by one selling stockholder.
The company states it will not receive any proceeds from sales by the selling stockholders; however, if the prefunded warrants are exercised for cash, Climb Bio will receive the exercise price. Shares outstanding were 57,263,023 as of May 14, 2026.